![]() ![]() Half of patients with advanced non-small cell lung cancer with MET exon 14 skipping mutations responded to the targeted agent ABN401, including six of eight patients with previously untreated disease, Abion announced. ![]() Preclinical studies suggested that combining the cholesterol-lowering drug lovastatin with a HER2-targeted antibody-drug conjugate may reduce the number of treatment cycles required for HER2-expressing cancers. A phase III trial of neoadjuvant therapy with the immunocytokine daromun met the primary endpoint of recurrence-free survival in fully resectable locally advanced melanoma, Philogen and Sun Pharma announced.Ī single injection of the HSV-1 oncolytic immunotherapy CAN-3110 led to a median overall survival of 11.6 months in recurrent high-grade glioma.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |